1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
FTI Consulting reported record fourth-quarter 2025 revenue of $990.7 million, up 10.7%, and full-year revenue of $3.789 billion, up 2.4%. Fourth-quarter EPS rose to $1.78 from $1.38 despite a $0.38 per-share charge for a valuation allowance on prior-year foreign deferred tax assets, and the company introduced 2026 guidance of $3.940 billion to $4.100 billion in revenue and $8.90 to $9.60 in EPS.
Q4 2025 revenue of $990.7 million, up from $894.9 million; diluted EPS of $1.78 versus $1.38 a year earlier
Full-year 2025 diluted EPS of $8.24 versus $7.81; full-year net income of $270.9 million versus $280.1 million
2026 guidance: revenue of $3.940 billion to $4.100 billion and EPS of $8.90 to $9.60
Repurchased $858.6 million of common stock in 2025; about $491.8 million remained under the buyback program at December 31, 2025
Monolithic Power Systems said its audit committee concluded that its 2024 annual financial statements and its 2025 quarterly statements should no longer be relied upon because of an unintentional error in accounting for deferred income taxes tied to a one-time foreign tax incentive. The restatement cuts 2024 net income by $194.6 million to $1.592 billion, while 2025 net income rises $5.6 million, and the company says revenue, its non-GAAP measures and its Q1 2026 outlook are unchanged.
2024 net income restated to $1.592 billion from $1.787 billion; diluted EPS restated to $32.60 from $36.59.
The error relates to deferred income taxes on a one-time tax incentive granted by a foreign jurisdiction; the company says it is non-cash and involved no misconduct.
2025 net income increases $5.6 million to $621.5 million; diluted EPS rises to $12.86 from $12.75.
Revenue and non-GAAP measures are unaffected, and the Q1 2026 business outlook from February 5, 2026 is unchanged; the 2025 Form 10-K will be filed immediately after this 8-K.
DTE Energy furnished audited 2025 financial statements for its indirect subsidiary DTE Gas Company, which show higher revenue and net income than in 2024. The filing is a subsidiary disclosure and does not change DTE Energy's own guidance, but it shows the gas utility's growth and a pending rate request that could raise its base rates.
Operating revenues were $2,033 million in 2025, up $250 million from $1,783 million in 2024, mainly from weather ($119 million) and gas cost recovery ($111 million).
Net income was $296 million in 2025, compared with $259 million in 2024; operating income was $498 million, compared with $438 million.
DTE Gas filed a rate case on November 13, 2025, requesting a net base rate increase of $163 million and a return on equity increase from 9.8% to 10.25%; a final MPSC order is expected in September 2026.
PricewaterhouseCoopers LLP issued an unqualified audit opinion dated February 27, 2026.
Saul Centers reported fourth-quarter 2025 total revenue of $75.1 million, up from $67.9 million a year earlier, while net income fell to $8.2 million from $10.4 million. Net income available to common stockholders dropped to $3.7 million, or $0.15 per share, from $5.3 million, or $0.22 per share, which the company attributes mainly to the start of operations at its Hampden House property.
Q4 2025 total revenue was $75.1 million, compared with $67.9 million in Q4 2024.
Q4 2025 net income available to common stockholders was $3.7 million, or $0.15 per diluted share, versus $5.3 million, or $0.22, a year earlier.
Hampden House, which opened October 1, 2025, reduced Q4 net income by $5.1 million, including a $2.8 million reduction in capitalized interest.
Funds from operations available to common stockholders and noncontrolling interests were $21.5 million, or $0.61 per share, versus $22.0 million, or $0.63, a year earlier.
HEI reported full-year 2025 net income of $123 million, or $0.71 per diluted share, compared with a net loss of $1,426 million, or $11.23 per share, in 2024, when a $1,875 million Maui wildfire tort-related provision was recorded. Excluding wildfire and strategic review costs, core income from continuing operations rose to $149 million, but core diluted EPS fell to $0.86 from $0.98, and full-year total revenues declined to $3,086.9 million from $3,219.9 million.
Full-year 2025 net income was $123 million, or $0.71 per diluted share, versus a net loss of $1,426 million, or $11.23 per share, in 2024.
Full-year 2025 core income from continuing operations was $149 million, or $0.86 per share, compared with $124 million, or $0.98 per share, in 2024.
Fourth quarter 2025 net income was $40 million, or $0.23 per share, compared with a net loss of $68 million, or $0.40 per share, in the fourth quarter of 2024.
Full-year 2025 total revenues were $3,086.9 million, compared with $3,219.9 million in 2024.
Where Food Comes From reported fourth-quarter and full-year 2025 results, with revenue and profit both lower than in 2024. Full-year total revenue fell to $24.9 million from $25.7 million and diluted EPS fell to $0.30 from $0.40, while the fourth quarter swung to a net loss. The filing furnishes the February 26, 2026 earnings press release and conference call transcript, which attribute the decline mainly to lower beef-related verification activity.
Full-year 2025 total revenue was $24.9 million vs. $25.7 million in 2024; diluted EPS was $0.30 vs. $0.40.
Fourth-quarter 2025 net loss of $0.2 million ($0.04 per diluted share) vs. net income of $1.0 million ($0.18) a year earlier.
Full-year net income included a $946,000 gain on sale of assets; cash from operations was $1.6 million vs. $2.7 million.
The company bought back 183,016 shares in 2025 and expects to continue repurchasing stock in 2026.
National HealthCare Corporation reported results for the year and quarter ended December 31, 2025, in a press release furnished under Item 2.02. Full-year net operating revenues and grant income rose 16.1% to $1.5 billion, and GAAP net income attributable to NHC rose to $120.0 million from $101.9 million. For shareholders, both revenue and reported profit increased, though the filing notes that the year's GAAP results include unrealized gains on marketable equity securities.
FY2025 net operating revenues and grant income: $1,517,781,000, up from $1,307,382,000 in 2024
FY2025 GAAP net income attributable to NHC: $120,015,000 (diluted EPS $7.67), up from $101,927,000 in 2024
FY2025 adjusted diluted EPS: $6.65, compared with $4.93 in 2024
Q4 2025 GAAP diluted EPS: $1.58, compared with $0.39 in Q4 2024; Q4 adjusted diluted EPS: $1.83, compared with $1.66
Arbor Realty Trust reported fourth-quarter 2025 net income of $14.6 million, or $0.07 per diluted share, down from $59.8 million, or $0.32, a year earlier. Full-year net income was $107.4 million, or $0.56 per diluted share, versus $1.18 in 2024. The board declared a $0.30 quarterly dividend, down from $0.43 declared in the fourth quarter of 2024.
Q4 2025 net income of $14.6 million, or $0.07 per diluted share, versus $0.32 in Q4 2024
Q4 2025 distributable earnings of $41.2 million, or $0.19 per diluted share, versus $0.40 in Q4 2024
Full-year 2025 net income of $107.4 million, or $0.56 per diluted share, versus $1.18 in 2024
Dividend of $0.30 per share payable March 24, 2026 to holders of record on March 10, 2026
Assured Guaranty Ltd. filed audited 2025 combined financial statements for its subsidiary Assured Guaranty Inc. and posted them on its website, along with a financial supplement and a fixed income investor presentation. The subsidiary reported total revenues of $806 million for 2025, up from $668 million in 2024, and net income attributable to Assured Guaranty Inc. of $437 million, up from $402 million. The filing covers the subsidiary only, not the parent's consolidated results.
Total revenues were $806 million in 2025, compared with $668 million in 2024.
Net income attributable to Assured Guaranty Inc. was $437 million in 2025, compared with $402 million in 2024.
Dividends paid to the parent were $287 million in 2025, compared with $400 million in 2024.
Total shareholder's equity was $5,485 million as of December 31, 2025, compared with $5,376 million a year earlier.
TransMedics added detail to its fourth-quarter 2025 results, showing that a $103.3 million release of a U.S. tax valuation allowance produced a $83.8 million net income tax benefit. At a 19.1% annual effective tax rate, fourth-quarter net income would be $17.5 million, or $0.47 per diluted share, versus the reported $105.4 million, or $2.62 per share. The company expects future quarterly tax provisions to be more in line with U.S. statutory rates.
Released $103.3 million U.S. tax valuation allowance in Q4 2025, producing an $83.8 million net income tax benefit
Reported Q4 2025 net income of $105.4 million ($2.62 per diluted share); adjusted net income of $17.5 million ($0.47 per share)
2025 annual effective tax rate was (77.0)%; excluding the release, it would have been 19.1%
Sunstone Hotel Investors reported fourth-quarter 2025 net income of $7.2 million, up from $0.8 million a year earlier, with total portfolio RevPAR up 9.6%. Full-year 2025 net income fell to $24.6 million from $43.3 million, though the company said it would have been $33.3 million excluding a loss on the June 2025 sale of the Hilton New Orleans St. Charles. The company also reauthorized a $500.0 million stock repurchase program and issued 2026 guidance.
Q4 2025 net income was $7.2 million versus $0.8 million; Adjusted EBITDA re rose 17.6% to $56.6 million.
Full-year 2025 Adjusted FFO per diluted share was $0.86, up 7.5%, and above the $0.835 midpoint of prior guidance of $0.80 to $0.87.
In February 2026 the board reauthorized repurchases of up to $500.0 million of common and preferred stock.
2026 guidance calls for net income of $21 to $46 million and Adjusted FFO per diluted share of $0.81 to $0.94.
Alpha Metallurgical Resources reported a fourth-quarter 2025 net loss of $17.3 million, or $1.34 per diluted share, compared with a $5.5 million loss in the third quarter and a $2.1 million loss a year earlier. For full-year 2025, the company posted a net loss of $61.7 million, or $4.75 per diluted share, after net income of $187.6 million in 2024, so shareholders are seeing a sharp reversal in profitability.
Q4 2025 net loss of $17.3 million ($1.34 per diluted share) vs. a $2.1 million loss in Q4 2024
Adjusted EBITDA of $28.5 million in Q4 2025, down from $41.7 million in Q3 2025 and $53.2 million in Q4 2024
Full-year 2025 total revenues of $2.13 billion vs. $2.96 billion in 2024
As of February 20, 2026, about 6.9 million shares repurchased for about $1.1 billion under a $1.5 billion authorization
CubeSmart reported fourth-quarter 2025 results on February 26, 2026, with diluted EPS down to $0.34 from $0.45 and FFO, as adjusted, per diluted share down 5.9% to $0.64. For the full year, diluted EPS fell to $1.46 from $1.72. The company also gave initial 2026 guidance of $1.55 to $1.63 in diluted EPS and $2.52 to $2.60 in FFO, as adjusted, per share, which shareholders can compare with 2025 results.
Q4 2025 net income attributable to common shareholders was $78.7 million, compared with $101.9 million in Q4 2024.
Same-store net operating income decreased 1.1% in Q4 2025, with same-store revenues down 0.1% and operating expenses up 2.9%.
2026 guidance: diluted EPS of $1.55 to $1.63 and FFO, as adjusted, per diluted share of $2.52 to $2.60; the filing does not state a prior guidance range.
TXNM Energy reported 2025 results on February 27, 2026. Electric operating revenues rose to $2.17 billion from $1.97 billion, but GAAP net earnings attributable to TXNM fell to $151.4 million from $242.2 million, and ongoing EPS dropped to $2.33 from $2.74. The company will not issue 2026 earnings guidance while its proposed $61.25-per-share acquisition by Blackstone Infrastructure is pending.
GAAP diluted EPS was $1.48 in 2025 versus $2.67 in 2024; ongoing diluted EPS was $2.33 versus $2.74.
Electric operating revenues were $2.17 billion in 2025 versus $1.97 billion in 2024.
GAAP 2025 results included a $58.8 million pension settlement charge and $43.1 million of costs related to the planned transaction.
No 2026 earnings guidance will be issued during the Blackstone transaction; closing is expected in the second half of 2026.
NIQ Global Intelligence reported fourth-quarter 2025 revenue of $1,139.1 million, up 9.2% year over year, and full-year revenue of $4,198.4 million, up 5.7%. The net loss attributable to NIQ narrowed to $32.2 million in the quarter and $353.3 million for the year, and the company introduced 2026 guidance along with a cost program that carries $50 million to $60 million of pre-tax restructuring charges.
Q4 2025 net loss attributable to NIQ was $32.2 million, compared with $172.9 million in Q4 2024.
Full-year 2025 adjusted EBITDA was $916.5 million, up 23.8%, and the adjusted EBITDA margin was 21.8%.
2026 full-year guidance calls for as-reported revenue of $4,439 million to $4,452 million and adjusted EBITDA of $1,043 million to $1,060 million.
In February 2026 the company approved a cost program expected to generate $55 million to $65 million of annualized savings by the end of 2026.
ANI Pharmaceuticals reported record fourth-quarter and full-year 2025 results, with Q4 net revenue of $247.1 million and GAAP net income available to common shareholders of $27.5 million, compared with a loss in the prior-year quarter. The company reaffirmed its full-year 2026 guidance, including total net revenue of $1,055 million to $1,115 million, which matters to shareholders as a reaffirmation rather than a change in outlook.
Q4 2025 net revenue was $247.1 million, up 29.6%; Cortrophin Gel rose 87.6% to $111.4 million, while Brands fell 37.9% to $12.3 million
Q4 GAAP diluted EPS was $1.18 versus a loss of $0.55 a year earlier; adjusted non-GAAP diluted EPS was $2.33 versus $1.63
Full-year 2025 net revenue was $883.4 million, up 43.8%, with GAAP net income available to common shareholders of $77.2 million
2026 guidance reaffirmed: total net revenue $1,055 million to $1,115 million and adjusted non-GAAP diluted EPS $8.83 to $9.34
Carter's reported fourth-quarter fiscal 2025 net sales of $925 million, up 7.6% from a year earlier, but adjusted diluted EPS fell 20.5% to $1.90 as tariff costs and other expenses weighed on margins. For the full year, adjusted diluted EPS fell 40.3% to $3.47, and the company expects adjusted diluted EPS to decline by a low double-digit to mid-teens percentage in fiscal 2026, excluding potential benefits from recent tariff developments.
Q4 net sales $925 million vs. $860 million; GAAP diluted EPS $1.76 vs. $1.71; adjusted diluted EPS $1.90 vs. $2.39
Fiscal 2025 net sales $2.898 billion vs. $2.844 billion; GAAP diluted EPS $2.53 vs. $5.12
Fiscal 2026 outlook: low double-digit to mid-teens decline in adjusted diluted EPS from $3.47; operating cash flow of $110 million to $120 million
Quarterly dividend of $0.25 per share declared February 19, 2026, payable March 27, 2026 to holders of record on March 13, 2026
Amneal Pharmaceuticals reported fourth-quarter 2025 net revenue of $814 million, up 11% from a year earlier, and GAAP net income attributable to the company of $35 million, compared with a loss of $31 million in the fourth quarter of 2024. For the full year, revenue rose 8% to $3.02 billion and adjusted diluted EPS was $0.83, and the company gave 2026 guidance of $3.05 billion to $3.15 billion in net revenue and $0.93 to $1.03 in adjusted diluted EPS, which is above 2025 results.
Q4 2025 net revenue was $814 million, up 11%, with Specialty up 38% and Affordable Medicines down 1%
Q4 2025 GAAP diluted EPS was $0.11 versus a loss of $0.10 a year earlier; adjusted diluted EPS was $0.21 versus $0.12
Full year 2025 net revenue was $3.02 billion and adjusted EBITDA was $688 million, up 10%
2026 guidance: net revenue of $3.05 billion to $3.15 billion, adjusted EBITDA of $720 million to $760 million, adjusted diluted EPS of $0.93 to $1.03
BrightSpring reported fourth-quarter 2025 revenue of $3,551 million, up 29.3%, and net income from continuing operations of $49.6 million, up from $4.3 million a year earlier. The company also initiated full-year 2026 revenue guidance of $14,450 million to $15,000 million and Adjusted EBITDA guidance of $760 million to $790 million, both excluding the Community Living business.
Q4 2025 Adjusted EBITDA was $184 million, up 40.7% from $130 million; full-year 2025 Adjusted EBITDA was $618 million, up 34.2%.
Full-year 2025 net income from continuing operations was $104.8 million, compared with a net loss of $68.9 million in 2024.
Leverage fell to 2.99x at December 31, 2025, from 4.16x a year earlier.
The Community Living divestiture to Sevita is expected to close by the end of the first quarter of 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.